Aggregation Reagents NEW | Behnk Elektronik

BE LTA Reagent SETs

Consistent. Reliable. Stable.

The BE LTA reagents are intended for the in vitro determination of platelet aggregation by light transmission aggregometry (LTA) on the Thrombomate XRA and on other semi-automated aggregometers. They are characterized by high quality and long stability to achieve reliable and high-quality results in platelet function diagnostics. The reagents contain the respective agonists and diluent to perform tests with customized dilutions.

With the BE X-Trays and BE LTA Reagent you achieve maximum flexibility on the Thrombomate XRA.

Multiple concentrations of the agonists with preset test applications are possible on the freely definable reagent trays to create a screening panel or to execute tests for differential diagnostics.

Adenosine diphosphate (ADP)

Aggregation agonist Adenosine diphosphate (ADP) intended for in-vitro determination of platelet aggregation by light transmission aggregometry (modified Born method) in platelet rich plasma (PRP).

Lyophilized Adenosine-5′- diphosphate; 100 µM
Dilution reagent and silicone caps included
Long stability after reconstitution

Thrombomate XRA test applications:
ADP 2,5 µM; ADP 5 µM; ADP 10 µM

Stability (reconstituted):
28 days at 2 – 8 °C

REF 057601:
2 x 1 ml ADP Reagent 100 µM
1 x 20 ml LTA Diluent
1 x 2 Silicone Caps

Lyophilized Adenosine-5′- diphosphate; 200 µM
Dilution reagent and silicone caps included
Long stability after reconstitution

Thrombomate XRA test applications:
ADP 5 µM; ADP 10 µM; ADP 20 µM

Stability (reconstituted):
28 days at 2 – 8 °C

REF 057602:
2 x 1 ml ADP Reagent 200 µM
1 x 20 ml LTA Diluent
1 x 2 Silicone Caps

Arachidonic acid (AA)

Aggregation agonist Arachidonic acid (AA) intended for in-vitro determination of platelet aggregation by light transmission aggregometry (modified Born method) in platelet rich plasma (PRP).

Lyophilized Arachidonic acid; 20 mM
Dilution reagent and silicone caps included
Long stability after reconstitution

Thrombomate XRA test applications:
AA 0,5 mM; AA 1 mM; AA 2 mM

Stability (reconstituted):
28 days at 2 – 8 °C

REF 057621:
2 x 1 ml AA Reagent 20 mM
1 x 20 ml LTA Diluent
1 x 2 Silicone Caps

Collagen (Col)

Aggregation agonist Collagen (Col) intended for in-vitro determination of platelet aggregation by light transmission aggregometry (modified Born method) in platelet rich plasma (PRP).

Lyophilized Collagen (fibrillar, from horse tendon); 50 µg/ml
Dilution reagent and silicone caps included
Long stability after reconstitution

Thrombomate XRA test applications:
Col 1 µg/ml; Col 2 µg/ml; Col 5 µg/ml

Stability (reconstituted):
28 days at 2 – 8 °C

REF 057611:
2 x 1 ml Col Reagent 50 µg/ml
1 x 20 ml LTA Diluent
1 x 2 Silicone Caps

Lyophilized Collagen (fibrillar, from horse tendon); 100 µg/ml
Dilution reagent and silicone caps included
Long stability after reconstitution

Thrombomate XRA test applications:
Col 2 µg/ml; Col 5 µg/ml; Col 10 µg/ml

Stability (reconstituted):
28 days at 2 – 8 °C

REF 057612:
2 x 1 ml Col Reagent 100 µg/ml
1 x 20 ml LTA Diluent
1 x 2 Silicone Caps

Epinephrine (Epi)

Aggregation agonist Epinephrine (Epi) intended for in-vitro determination of platelet aggregation by light transmission aggregometry (modified Born method) in platelet rich plasma (PRP).

Lyophilized Epinephrine ((R)-1-(3,4-Dihydroxyphenyl)-2-(N-methyl amino)-ethanol), as bitartrate; 100 µM
Dilution reagent and silicone caps included
Long stability after reconstitution

Thrombomate XRA test applications:
Epi 5 µM; Epi 10 µM

Stability (reconstituted):
28 days at 2 – 8 °C

REF 057631:
2 x 1 ml Epi Reagent 100 µM
1 x 20 ml LTA Diluent
1 x 2 Silicone Caps

Thrombin receptor-activating peptide (TRAP)

Aggregation agonist Thrombin receptor-activating peptide (TRAP) intended for in-vitro determination of platelet aggregation by light transmission aggregometry (modified Born method) in platelet rich plasma (PRP).

Lyophilized Thrombin receptor PAR-1 activating peptide (S-F-L-L-R-N); 0.5 mM
Dilution reagent and silicone caps included
Long stability after reconstitution

Thrombomate XRA test applications:
TRAP 10 µM; TRAP 20 µM; TRAP 50 µM

Stability (reconstituted):
28 days at 2 – 8 °C

REF 057641:
2 x 1 ml TRAP Reagent 0.5 mM
1 x 20 ml LTA Diluent
1 x 2 Silicone Caps

Lyophilized Thrombin receptor PAR-1 activating peptide (S-F-L-L-R-N); 1.0 mM
Dilution reagent and silicone caps included
Long stability after reconstitution

Thrombomate XRA test applications:
TRAP 20 µM; TRAP 50 µM; TRAP 100 µM

Stability (reconstituted):
28 days at 2 – 8 °C

REF 057642:
2 x 1 ml TRAP Reagent 1.0 mM
1 x 20 ml LTA Diluent
1 x 2 Silicone Caps

Ristocetin (Ris)

Aggregation agonist Ristocetin (Ris) intended for in-vitro determination of platelet aggregation by light transmission aggregometry (modified Born method) in platelet rich plasma (PRP).

Lyophilized Ristocetin, an antibiotic that agglutinates platelets in the presence of von Willebrand Factor; 15 mg/ml
Dilution reagent and silicone caps included
Long stability after reconstitution

Thrombomate XRA test applications:
Ris 0,6 mg/ml; Ris 1,2 mg/ml
Ris 0,5 mg/ml; Ris 1,0 mg/ml

Stability (reconstituted):
28 days at 2 – 8 °C

REF 057651:
2 x 1 ml Ris Reagent 15 mg/ml
1 x 20 ml LTA Diluent
1 x 2 Silicone Caps

Spontaneous aggregation

Reagent container for the detection of spontaneous platelet aggregation (SPA) by light transmission aggregometry in platelet rich plasma (PRP) on Thrombomate XRA.